Galapagos expands fibrosis research collaboration with Fibrocor
Galapagos has expanded its research collaboration with Candian firm Fibrocor Therapeutics, which develops tissue-specific therapeutics...
Read More...
Focus:
Belgium
-
Promethera closes Series D funding round to support expansion
Cell-based drugs developer Promethera Biosciences has closed a Series D financing round to support its...
Read More...
-
![Newpharma collaborates with Ingenico for e-payments]()
Newpharma collaborates with Ingenico for e-payments
Belgian online pharmacy firm Newpharma has partnered with UK-based payments company Ingenico Group to enable...
Read More...
-
![UCB acquires Ra Pharma]()
UCB acquires Ra Pharma for $2.1bn to enrich its rare disease portfolio
UCB has acquired Massachusetts-based Ra Pharmaceuticals for $48 per share, bringing the total transaction to...
Read More...
-
![UCB to acquire Ra Pharma]()
UCB to acquire Ra Pharmaceuticals in $2.1bn deal
Belgian biopharmaceutical firm UCB has signed a merger agreement to acquire US-based Ra Pharmaceuticals for...
Read More...
-
![Gilead and Galapagos R&D deal]()
Gilead and Galapagos deal: building on filgotinib agreement
US-based Gilead has entered into a ten-year global research and development (R&D) collaboration agreement with...
Read More...
-
![Gilead and Galapagos deepen R&D alliance]()
Gilead and Galapagos deepen R&D alliance with ten-year deal
Gilead Sciences has expanded its partnership with Belgian biotech company Galapagos with a ten-year global...
Read More...
-
![chronic lymphocytic leukaemia]()
Imbruvica receives positive opinion from CHMP
The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended...
Read More...
-
Janssen to use Iktos’ AI technology for drug discovery
Janssen Pharmaceutica has initiated a collaboration agreement to use Iktos’ artificial intelligence (AI) technology to...
Read More...
-
![Brussels aims to attract UK pharma business post-Brexit]()
Brussels aims to attract UK pharma business post-Brexit
The Brussels Capital Region has launched a major campaign to attract UK-based pharmaceutical and life...
Read More...
